Talis Biomedical Corp expected to post a loss of 68 cents a share - Earnings Preview

Talis Biomedical

10/03/2023 11:05

* Talis Biomedical Corp  TLIS.OQ   TLIS.O  is expected
to show a
fall in quarterly revenue when it reports  results on March 13
(estimated). 
    * The Redwood City California-based  company is expected to
report
 a 6.8% decrease in revenue to $800 thousand from $858 thousand
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Talis Biomedical
Corp is
for a loss of 68 cents per share. 
    * The current average analyst rating on the shares is "sell"
and
the breakdown of recommendations is no "strong buy" or "buy," no
"hold" and 2 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Talis
Biomedical
Corp is $0.4​, below​ its last closing price of $0.58. ​​​

This summary was machine generated March 10 at 11:05 GMT.  All
figures in US dollars  unless otherwise stated